Latest Regulatory News

Renergen Limited and ASP Isotopes Inc. have secured crucial regulatory approvals and agreed to extend the deadline for completing their Scheme of Arrangement to January 2026, signaling steady progress in their strategic partnership.

Everest Metals Corporation has reported impressive rubidium assay results up to 0.79% Rb₂O from its Phase 2 drilling at the Mt Edon Critical Mineral Project, reinforcing the potential for resource expansion ahead of a planned upgrade in early 2026.

Sabre Resources has reported significant rare earth and critical metal anomalies at its Dingo Project in the Northern Territory, highlighting promising concentrations of key magnet metals Neodymium and Praseodymium. The company plans follow-up drilling to further evaluate these discoveries.

Vysarn Limited has reported record FY25 profits and is aiming for a 33% NPBT increase in FY26, driven by acquisitions and progress on the Kariyarra Water Scheme. The company is expanding its national footprint amid growing water demand in mining and infrastructure sectors.

Amplia Therapeutics reported a $4.18 million half-year loss but bolstered its cash reserves with a $27.6 million capital raise to advance clinical trials of its lead drug narmafotinib, showing encouraging interim data in pancreatic cancer.

Southern Cross Gold has secured approval for its underground exploration tunnel at the Sunday Creek project, marking a pivotal step towards mine development and enhanced resource definition.

The Federal Court of Australia has approved the acquisition scheme for Lynch Group Holdings, paving the way for a cash payout to shareholders and imminent trading suspension.

QGold Pty Ltd has initiated an unconditional on-market takeover offer for all shares in Venus Metals Corporation Limited at a 21% premium, aiming to consolidate control and potentially delist the explorer.

Thunderbird Resources has completed its acquisition of LM2 Metals, gaining full ownership of the Springfield Gold Deposit in central NSW and issuing over 28 million shares as part of the deal.

Uscom Limited reported a 25% revenue decline in FY25 amid global geopolitical challenges but reinforced its commitment to growth through strategic partnerships and innovative medical technologies.

Hexima Limited reveals plans to return capital to shareholders and restructure its board following the closure of its main clinical program and prolonged ASX trading suspension.

Kingsgate Consolidated Limited reported record quarterly gold and silver production at its Chatree Gold Mine, alongside strong cash growth and strategic project advances in its November 2025 AGM update.